SCHEMBL19207780

SCHEMBL19207780

CN1C(=O)C(NC(=O)c2nnc(Cc3ccccc3)o2)CCc2ccccc21

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 18/20 1.00
SCN9A Q15858 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19207776 1.00 RIPK1 (1.00) RIPK1SCN9A
SCHEMBL19207594 0.87 RIPK1 (1.00) RIPK1
SCHEMBL19207598 0.87 RIPK1 (1.00) RIPK1
SCHEMBL19207701 0.87 RIPK1 (1.00) RIPK1
SCHEMBL23337325 0.85 RIPK1 (0.73) RIPK1
SCHEMBL19224464 0.84 RIPK1 (0.79) RIPK1
SCHEMBL23349411 0.84 RIPK1 (0.77) RIPK1
SCHEMBL17312455 0.83 RIPK1 (1.00) RIPK1
SCHEMBL17312459 0.83 RIPK1 (1.00) RIPK1
SCHEMBL23337962 0.83 RIPK1 (0.70) RIPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3414239-A2 INHIBITORS OF RECEPTOR-INTERACTING PROTEIN KINASE 1 Denali Therapeutics Inc. (US) 2018-12-19 EP disclosed
WO-2017136727-A2 COMPOUNDS, COMPOSITIONS AND METHODS DENALI THERAPEUTICS INC. (US) 2017-08-10 WO disclosed